Literature DB >> 6116954

Haemodynamic effects of beta-blockade in ischaemic heart failure.

S H Taylor, B Silke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6116954     DOI： 10.1016/s0140-6736(81)91105-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Mortality in heart failure: clinical variables of prognostic value.

Authors:  J G Cleland; H J Dargie; I Ford
Journal:  Br Heart J       Date:  1987-12

Review 2.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

3.  Initiation and maintenance of beta-blockade with intravenous oxprenolol.

Authors:  B Silke; V A John; R T Calvert; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.

Authors:  J G Cleland; H J Dargie; I N Findlay; J T Wilson
Journal:  Br Heart J       Date:  1987-05

5.  Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.

Authors:  S H Taylor; B Silke; G I Nelson; R C Okoli; R C Ahuja
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

6.  Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.

Authors:  B Silke; M A Frais; S P Verma; G Reynolds; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.